• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性子宫切除术治疗早期宫颈癌后复发风险的术后列线图预测。

Postoperative nomogram predicting risk of recurrence after radical hysterectomy for early-stage cervical cancer.

机构信息

Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Korea.

出版信息

Int J Gynecol Cancer. 2010 Dec;20(9):1581-6.

PMID:21370600
Abstract

OBJECTIVE

The aim of this study was to develop a nomogram for predicting the 5-year disease-free survival (DFS) after radical hysterectomy for early-stage cervical cancer.

PATIENTS AND METHODS

An institutional database of 275 consecutive patients treated at Seoul National University Hospital for stage I to stage IIA cervical cancer was used to develop a nomogram based on Cox proportional hazards regression model. The developed nomogram was internally validated with bootstrapping, and performance was assessed by concordance index and a calibration curve. External validation was also performed using an independent data set of patients from Asan Medical Center.

RESULTS

From Cox regression analysis, disease stage, number of positive lymph nodes, parametrial involvement, and depth of invasion were identified as independent risk factors for disease recurrence (P < 0.05). The nomogram incorporating these factors appeared to be accurate and predicted the outcomes better than the International Federation of Gynecology and Obstetrics stage alone (concordance index, 0.858 compared with 0.719; P = 0.001). When applied to a separate validation set, the nomogram also showed similar predictive accuracy (concordance index, 0.879).

CONCLUSION

We have developed a nomogram that can predict the recurrence risk in patients with early-stage cervical cancer after surgery, which was internally and externally validated.

摘要

目的

本研究旨在为早期宫颈癌根治性子宫切除术的 5 年无病生存率(DFS)建立一个列线图预测模型。

患者与方法

本研究使用了首尔国立大学医院的 275 例连续宫颈癌患者的机构数据库,基于 Cox 比例风险回归模型建立了一个列线图。通过自举法对内部分值进行了验证,并通过一致性指数和校准曲线评估了性能。使用来自 Asan 医疗中心的独立患者数据集进行了外部验证。

结果

通过 Cox 回归分析,疾病分期、阳性淋巴结数量、宫旁侵犯和浸润深度被确定为疾病复发的独立危险因素(P < 0.05)。纳入这些因素的列线图似乎更准确,预测结果优于国际妇产科联合会(FIGO)分期单独使用(一致性指数,0.858 与 0.719;P = 0.001)。当应用于单独的验证集时,该列线图也显示出类似的预测准确性(一致性指数,0.879)。

结论

我们已经开发了一个列线图,可以预测手术后早期宫颈癌患者的复发风险,该列线图经过了内部和外部验证。

相似文献

1
Postoperative nomogram predicting risk of recurrence after radical hysterectomy for early-stage cervical cancer.根治性子宫切除术治疗早期宫颈癌后复发风险的术后列线图预测。
Int J Gynecol Cancer. 2010 Dec;20(9):1581-6.
2
Adjuvant platinum-based chemotherapy for early stage cervical cancer.早期宫颈癌的铂类辅助化疗。
Cochrane Database Syst Rev. 2016 Nov 22;11(11):CD005342. doi: 10.1002/14651858.CD005342.pub4.
3
The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.宫颈癌 IIIC-r 期 5 年总生存率与 I 期和 II 期无明显差异:单中心回顾性分析。
BMC Cancer. 2021 Feb 27;21(1):203. doi: 10.1186/s12885-021-07890-w.
4
Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.术前磁共振成像中肿瘤直径对 FIGO 分期 IB1 期宫颈癌的宫旁浸润的诊断影响。
Int J Gynecol Cancer. 2011 Feb;21(2):349-54.
5
Adjuvant platinum-based chemotherapy for early stage cervical cancer.早期宫颈癌的铂类辅助化疗。
Cochrane Database Syst Rev. 2012 Jun 13;6(6):CD005342. doi: 10.1002/14651858.CD005342.pub3.
6
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.根治性子宫切除术联合放化疗与单纯根治性子宫切除术治疗局部晚期宫颈癌的疗效比较
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD010260. doi: 10.1002/14651858.CD010260.pub3.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Outcomes of Laparoscopic Radical Hysterectomy in Ia1-Ib1 Cervical Cancer Patients: A Multi-Center Study with 10 Years' Experiences in the Real World.Ia1-Ib1期宫颈癌患者腹腔镜根治性子宫切除术的结局:一项具有10年真实世界经验的多中心研究
Ann Surg Oncol. 2025 Mar;32(3):2213-2222. doi: 10.1245/s10434-024-16637-3. Epub 2024 Dec 29.
9
Establishment of a prognostic nomogram and risk stratification system for patients with distant-metastatic hepatocellular carcinoma: A population-based study.远处转移肝细胞癌患者预后列线图及风险分层系统的建立:一项基于人群的研究。
Medicine (Baltimore). 2025 Jun 13;104(24):e42834. doi: 10.1097/MD.0000000000042834.
10
Identification of Patients with Early-Stage Hepatocellular Carcinoma Benefiting from Neoadjuvant Chemotherapy-A SEER-Based Study.基于监测、流行病学和最终结果(SEER)数据库研究:识别从新辅助化疗中获益的早期肝细胞癌患者
J Gastrointest Cancer. 2025 Jun 29;56(1):144. doi: 10.1007/s12029-025-01264-2.

引用本文的文献

1
Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer.术前淋巴细胞、白蛋白和中性粒细胞指数(LANR)对 IB-IIA 期宫颈癌患者的预后意义。
PLoS One. 2023 Sep 20;18(9):e0290905. doi: 10.1371/journal.pone.0290905. eCollection 2023.
2
Predicting the Recurrence of Operable Cervical Cancer Patients Based on Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and Classical Clinicopathological Parameters.基于血红蛋白、白蛋白、淋巴细胞和血小板(HALP)评分及经典临床病理参数预测可手术宫颈癌患者的复发情况
J Inflamm Res. 2022 Sep 12;15:5265-5281. doi: 10.2147/JIR.S383742. eCollection 2022.
3
Development and Validation of a Nomogram for Predicting Postoperative Distant Metastasis in Patients with Cervical Cancer.
建立并验证一个列线图预测宫颈癌患者术后远处转移的模型。
Med Sci Monit. 2022 Apr 12;28:e933379. doi: 10.12659/MSM.933379.
4
Effects of Continuous Catheterization on Reducing Postoperative Urinary Tract Infection in Cervical Cancer Patients with Double J Stent Placement.双 J 管置入术对宫颈癌术后患者留置导尿减少尿路感染的效果观察
J Healthc Eng. 2021 Nov 9;2021:9299001. doi: 10.1155/2021/9299001. eCollection 2021.
5
The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.宫颈癌患者个体化监测策略的年度复发风险模型。
Eur J Cancer. 2021 Oct 16;158:111-122. doi: 10.1016/j.ejca.2021.09.008.
6
Prediction Models for Prognosis of Cervical Cancer: Systematic Review and Critical Appraisal.预测宫颈癌预后的模型:系统评价和批判性评估。
Front Public Health. 2021 May 7;9:654454. doi: 10.3389/fpubh.2021.654454. eCollection 2021.
7
HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix.HER3蛋白表达作为早期宫颈癌腺癌和腺鳞癌患者术后复发的危险因素。
Oncol Lett. 2020 Oct;20(4):38. doi: 10.3892/ol.2020.11899. Epub 2020 Jul 23.
8
Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage IB-IIA cervical cancer.术前纤维蛋白原-白蛋白比值:IB-IIA 期宫颈癌患者的潜在预后因素。
BMC Cancer. 2020 Jul 25;20(1):691. doi: 10.1186/s12885-020-07191-8.
9
The Prognostic Significance Of Pretreatment Albumin/alkaline Phosphatase Ratio In Patients With Stage IB-IIA Cervical Cancer.IB-IIA期宫颈癌患者治疗前白蛋白/碱性磷酸酶比值的预后意义
Onco Targets Ther. 2019 Nov 12;12:9559-9568. doi: 10.2147/OTT.S225294. eCollection 2019.
10
Survival prediction models for patients with anal carcinoma receiving definitive chemoradiation: A population-based study.接受根治性放化疗的肛管癌患者的生存预测模型:一项基于人群的研究。
Oncol Lett. 2020 Feb;19(2):1443-1451. doi: 10.3892/ol.2019.11238. Epub 2019 Dec 23.